Noelle Frey, MD, a hematologist-oncologist at Penn Medicine and the Abramson Cancer Center, presents a summary of approaches to the myelodysplastic syndromes with a focus upon improved prognosis and the application of novel drug therapies.
Related Links
Published
August 14, 2014
Created by
BROADCASTMED